Clinical Trials Sponsored by Coram Clinical Trials

Total 2325 results

Coram Clinical Trials

Completed

Immunoglobulin, Diagnosis, Evaluation, and Key Learnings Patient Registry (IDEaL™) (IDEaL)

IVIg or SCIg Therapy in the Home or at Alternate Site

United States
Coram Clinical Trials

Completed

AL1TER™: Alpha-1 Therapy, Evaluation, and Research Patient Registry (AL1TER)

Alpha-1 Anti-trypsin Deficiency

United States
Coram Clinical Trials

Active, not recruiting

Health Evaluation And Learning for Total Parenteral Nutrition (TPN) at Home Patient Registry (HEALTH)

Malnutrition | Patients Requiring Home Parenteral Nutrition

United States
BioGaia AB
Atlantia Food Clinical Trials; CTC Clinical Trial Consultants AB

Recruiting

Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying Time in Infants With Colic

Colic, Infantile

Ireland, Sweden
EV Clinical Trials

Completed

Lifitegrast 5% Ophthalmic Solution and Contact Lens Dryness

Contact Lens Discomfort | Contact Lens | Contact Lens Dryness

United States
ProgenaBiome
Ventura Clinical Trials

Not yet recruiting

Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders

Autism Spectrum Disorder | Autism

United States
Aptinyx
Worldwide Clinical Trials

Completed

Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia

Fibromyalgia

United States
Aptinyx
Worldwide Clinical Trials

Terminated

Safety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSD

PTSD

United States
MicuRx
Worldwide Clinical Trials

Completed

Single Dose Escalation and Multiple Dose Escalation Trial of an Intravenous Formulation of MRX-4

Safety
Atlantia Food Clinical Trials

Terminated

Effect of Protein Hydrolysates on HbA1c Levels in Pre-diabetics

PreDiabetes

Ireland
Atlantia Food Clinical Trials

Completed

Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild Indigestion

HELICOBACTER INFECTION

Ireland
MicuRx
Worldwide Clinical Trials

Completed

Single Dose and Multiple Dose Escalation Trial of an Oral Formulation of MRX-4

Safety
Aptinyx
Worldwide Clinical Trials

Completed

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)

Diabetic Peripheral Neuropathic Pain

United States
Atlantia Food Clinical Trials

Completed

An Intervention Study Evaluating the Effects of a Raspberry Leaf Extract in an Osteoarthritic Population.

Osteoarthritis, Knee

Ireland
Atlantia Food Clinical Trials

Completed

A Study to Evaluate the Effects of a Natural Supplement in Adults With Chronic Functional Constipation

Constipation

Ireland
ProJenX
Worldwide Clinical Trials

Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers (PRO-101)

Amyotrophic Lateral Sclerosis

United States
Atlantia Food Clinical Trials

Completed

Study to Investigate the Effect of Superba Boost on the Skin

Trans-epidermal Water Loss

Ireland
Mayo Clinic
Alliance for Clinical Trials in Oncology

Terminated

Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

United States
NCIC Clinical Trials Group

Completed

Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

Canada, Brazil
NCIC Clinical Trials Group

Completed

Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma

Lymphoma

Canada
NCIC Clinical Trials Group

Completed

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

Breast Cancer | Osteoporosis

United States, Canada
NCIC Clinical Trials Group

Completed

Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

Canada
NCIC Clinical Trials Group

Completed

AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer

Colorectal Cancer | Lung Cancer

Canada
NCIC Clinical Trials Group

Completed

OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

Canada
NCIC Clinical Trials Group

Completed

AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Canada
NCIC Clinical Trials Group

Completed

Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma

Lymphoma

Canada
NCIC Clinical Trials Group

Completed

SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Colorectal Cancer

Canada
NCIC Clinical Trials Group

Completed

Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Sarcoma

Canada, United States
NCIC Clinical Trials Group

Completed

Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx

Head and Neck Cancer | Oral Complications

Canada
NCIC Clinical Trials Group

Completed

Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

Canada, United Kingdom
NCIC Clinical Trials Group

Completed

Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer

Endometrial Cancer
NCIC Clinical Trials Group

Completed

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

Lung Cancer

United States, Spain, Canada, Italy, France, Switzerland, Netherlands, Belgium, Germany, Finland, United Kingdom, Poland, Portugal, Austria
NCIC Clinical Trials Group

Completed

ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer

Canada
NCIC Clinical Trials Group

Completed

Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery

Endometrial Cancer

Canada, United States, Australia
NCIC Clinical Trials Group

Completed

MG98 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States, Canada
NCIC Clinical Trials Group

Completed

Theophylline in Treating Cancer Patients With Shortness of Breath

Quality of Life | Unspecified Adult Solid Tumor, Protocol Specific | Pulmonary Complications

Canada
NCIC Clinical Trials Group

Completed

Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer

Breast Cancer

United States, Canada
NCIC Clinical Trials Group

Completed

Combination Chemotherapy in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

Canada, United States
NCIC Clinical Trials Group

Completed

Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

Breast Cancer

Canada, United States
NCIC Clinical Trials Group

Completed

Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation

Lymphoma

Canada
NCIC Clinical Trials Group

Completed

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

Breast Cancer | Neutropenia

Canada
NCIC Clinical Trials Group

Completed

Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma (IDEC-C2B8)

Lymphoma

Canada
NCIC Clinical Trials Group

Terminated

Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain

Pain | Unspecified Adult Solid Tumor, Protocol Specific | Sleep Disorders | Nausea and Vomiting

Canada
NCIC Clinical Trials Group

Completed

Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone Metastases

Bone Metastases

Canada
NCIC Clinical Trials Group

Completed

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Lymphoma

United States, Canada, Australia
NCIC Clinical Trials Group

Completed

Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma

Melanoma

Canada, United States
NCIC Clinical Trials Group

Completed

Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer

Colorectal Cancer

Canada
NCIC Clinical Trials Group

Completed

Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma

Lymphoma

Canada
NCIC Clinical Trials Group

Completed

Bortezomib in Treating Patients With Mantle Cell Lymphoma

Lymphoma

Canada
NCIC Clinical Trials Group

Terminated

Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer (DART)

Prostate Cancer

Canada

3

Subscribe